miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma.
about
Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencingSuppression of breast tumor growth and metastasis by an engineered transcription factormiRNAs Signature in Head and Neck Squamous Cell Carcinoma Metastasis: A Literature ReviewThe role of miRNAs in cutaneous squamous cell carcinomaRoles of the canonical myomiRs miR-1, -133 and -206 in cell development and diseaseMicroRNA expression characterizes oligometastasis(es)Tumor suppressor miR-1 restrains epithelial-mesenchymal transition and metastasis of colorectal carcinoma via the MAPK and PI3K/AKT pathway.Expression profile analysis of head and neck squamous cell carcinomas using data from The Cancer Genome Atlas.MicroRNA-1 (miR-1) inhibits chordoma cell migration and invasion by targeting slugDeep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAsRole of microRNA-1 in human cancer and its therapeutic potentials.MiR-133b regulates the expression of the Actin protein TAGLN2 during oocyte growth and maturation: a potential target for infertility therapy.miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer.Identification of tumour suppressive microRNA-451a in hypopharyngeal squamous cell carcinoma based on microRNA expression signature.A quest for miRNA bio-marker: a track back approach from gingivo buccal cancer to two different types of precancersTumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinomaPhospho-ΔNp63α/miR-885-3p axis in tumor cell life and cell death upon cisplatin exposure.Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma.microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers.Tumor suppressive microRNA‑138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma.MicroRNA-1 in Cardiac Diseases and CancersEZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma.Label-free quantitative phosphorylation analysis of human transgelin2 in Jurkat T cells reveals distinct phosphorylation patterns under PKA and PKC activation conditionsGenomic analyses of the RNA-binding protein Hu antigen R (HuR) identify a complex network of target genes and novel characteristics of its binding sites.HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs.MicroRNA-1 induces apoptosis by targeting prothymosin alpha in nasopharyngeal carcinoma cellsRegulation of senescence by microRNA biogenesis factorsMiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis.MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF.Targeting pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progressionDownregulation of microRNA‑33a promotes cyclin‑dependent kinase 6, cyclin D1 and PIM1 expression and gastric cancer cell proliferation.MicroRNA-1 (miR-1) inhibits gastric cancer cell proliferation and migration by targeting MET.Cell-free Circulating miRNA Biomarkers in CancerA targeted proteomic strategy for the measurement of oral cancer candidate biomarkers in human saliva.Abnormal expression of miR-1 in breast carcinoma as a potent prognostic factor.Identification of differentially expressed signatures of long non-coding RNAs associated with different metastatic potentials in gastric cancer.Differential expression of miR-1, a putative tumor suppressing microRNA, in cancer resistant and cancer susceptible miceIdentification of potential therapeutic target genes and mechanisms in head and neck squamous cell carcinoma by bioinformatics analysis.Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma.Lin28b promotes head and neck cancer progression via modulation of the insulin-like growth factor survival pathway
P2860
Q21134708-ABE2685E-AC19-4544-A87A-6621D67B299EQ21135222-45342A6D-B9EB-4C9C-86D6-D4E2FF67F3BAQ26747138-3424DE56-9BAB-44A0-932E-00C1B4C52379Q26778339-060CE0C6-B01F-468C-AE82-4D9849AC8502Q26795757-D94FE796-8CB0-43CB-8AD1-5B86CC6D2304Q27311314-FB5ECCC1-72A9-48C9-910A-D11800C2F5E1Q30009323-51245D73-01BA-47EE-81E6-70BE219C3320Q31066455-0106E8E9-8927-4438-A1CA-B34A8E5D9AF4Q33275231-F9F76191-3D25-4553-9152-8EEF77AF8278Q33728303-265204D1-556C-44A8-969F-02C6BDEB5158Q33737275-A704A9FF-065D-4926-B99E-48CD936A1DD2Q33800459-75528A68-CDBC-42FA-AD3D-4D3366266F1BQ33802900-2FC93173-795B-4E73-AC59-20251B32EB75Q33918123-ED308DEC-41A2-4E9F-A0D7-2A3975352E4EQ34050751-6F02F298-DA62-411F-BB36-0910B92A5967Q34208496-5ACBF7B7-0CAC-4500-9D70-56516973E381Q34231282-E586DB2E-AB51-450B-B90E-34EFB5AA487EQ34251059-586CDFF3-A59F-47C6-8070-24ACBEDCCF43Q34252329-C3CBB48E-82E1-498E-9D78-B17FD38459BCQ34286271-18D8DEC1-9C21-410E-830A-7CFB6844CC82Q34412493-75866FB8-A138-4E00-8553-B85D4E1E8919Q34956954-012D7818-2F14-42FE-8A28-12FA746E0907Q35257997-52223066-A04E-4300-BC88-9543CC7C7B0AQ35423239-C213DE7E-CC0D-4A05-B20C-93B954B1A251Q35562611-D7A16464-9399-406F-8FE4-6726C6CEAF5DQ35614884-39AE2F07-9615-47E3-8951-5036C052FA35Q35948994-A0CFCEAE-B6A0-4A69-92B0-8DB698268298Q35955250-938C60E4-E514-41D2-8244-372A95BDD707Q36012772-5EEE8D6D-725C-4AB9-8301-6DA3FB77AD6FQ36021066-136F3E0D-CD3D-464F-85E2-79C1D89C9596Q36224976-38E1B6DB-988C-474F-ACB3-8373131F503DQ36278121-18EEB242-933A-4731-918C-8303E362B7B0Q36316601-5908FE5B-81C4-4AEB-86A0-B9EDEB8D8A5BQ36436952-02A3CAA7-790E-49E3-A2F1-85F865FE834CQ36467434-79E5A057-2563-42E2-A54E-904923589495Q36547631-6DEC9E97-626B-4E04-92B8-7CE195156CA6Q36812809-0835EB7E-C4FB-415D-BF06-903E0972A38FQ36824825-CD7E3030-E390-4192-805E-88ABE36B7524Q36889632-58E4EA79-A64B-46B3-BF00-A761698BF03FQ36926139-87A8C176-415F-43A6-9B6A-877EB774792D
P2860
miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
miR-1 as a tumor suppressive m ...... neck squamous cell carcinoma.
@ast
miR-1 as a tumor suppressive m ...... neck squamous cell carcinoma.
@en
type
label
miR-1 as a tumor suppressive m ...... neck squamous cell carcinoma.
@ast
miR-1 as a tumor suppressive m ...... neck squamous cell carcinoma.
@en
prefLabel
miR-1 as a tumor suppressive m ...... neck squamous cell carcinoma.
@ast
miR-1 as a tumor suppressive m ...... neck squamous cell carcinoma.
@en
P2093
P2860
P356
P1433
P1476
miR-1 as a tumor suppressive m ...... neck squamous cell carcinoma.
@en
P2093
Hideki Enokida
Hirofumi Yoshino
Kazumori Kawakami
Makio Shozu
Masayuki Nakagawa
Naohiko Seki
Naoko Kikkawa
Nijiro Nohata
Takeshi Chiyomaru
P2860
P356
10.18632/ONCOTARGET.213
P407
P577
2011-01-01T00:00:00Z